BMC Musculoskeletal Disorders

Table 6 Maximum torque (N-mm)

From: Treatment of critically sized femoral defects with recombinant BMP-2 delivered by a modified mPEG-PLGA biodegradable thermosensitive hydrogel

	Untreated (n = 6)	Autograft (n = 6)	BOX hydrogel + BMP-2 (μg/ml) (n = 6)
	Untreated (n = 6)	Autograft (n = 6)	0	5	10	20
	30	588	38	565	798	1215
	26	750	15	885	695	995
	36	665	55	750	1006	685
	10	840	26	852	658	598
	26	780	31	648	612	1305
	18	655	26	698	856	658
Mean ± SD	24.3 ± 8.4	713.0 ± 84.9^a	31.8 ± 12.4	733.0 ± 111.2^a	770.8 ± 133.5^a	909.3 ± 279.2^a

^aP < 0.05 compared to the untreated group. n = 6 in each group

Back to article page

ISSN: 1471-2474

Contact us

Submission enquiries: bmcmusculoskeletaldisorders@biomedcentral.com
General enquiries: ORSupport@springernature.com